nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0453	0.0642	CbGbCtD
Finasteride—CYP3A7—Carbamazepine—epilepsy syndrome	0.0379	0.0537	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.0379	0.0537	CbGbCtD
Finasteride—CYP3A7—Phenytoin—epilepsy syndrome	0.034	0.0482	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.034	0.0482	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.0303	0.0429	CbGbCtD
Finasteride—CYP3A7—Phenobarbital—epilepsy syndrome	0.0303	0.0429	CbGbCtD
Finasteride—CYP3A7—Midazolam—epilepsy syndrome	0.0299	0.0423	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.0299	0.0423	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.0287	0.0407	CbGbCtD
Finasteride—CYP3A7—Diazepam—epilepsy syndrome	0.0287	0.0407	CbGbCtD
Finasteride—CYP3A5—Carbamazepine—epilepsy syndrome	0.0284	0.0403	CbGbCtD
Finasteride—CYP3A5—Phenytoin—epilepsy syndrome	0.0255	0.0361	CbGbCtD
Finasteride—CYP3A5—Phenobarbital—epilepsy syndrome	0.0227	0.0322	CbGbCtD
Finasteride—CYP3A5—Midazolam—epilepsy syndrome	0.0224	0.0318	CbGbCtD
Finasteride—CYP3A5—Diazepam—epilepsy syndrome	0.0216	0.0305	CbGbCtD
Finasteride—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0177	0.025	CbGbCtD
Finasteride—CYP3A5—Valproic Acid—epilepsy syndrome	0.017	0.0241	CbGbCtD
Finasteride—CYP3A4—Felbamate—epilepsy syndrome	0.0164	0.0233	CbGbCtD
Finasteride—CYP3A4—Trimethadione—epilepsy syndrome	0.0164	0.0233	CbGbCtD
Finasteride—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0154	0.0219	CbGbCtD
Finasteride—CYP3A4—Clonazepam—epilepsy syndrome	0.014	0.0198	CbGbCtD
Finasteride—CYP3A4—Clobazam—epilepsy syndrome	0.0134	0.019	CbGbCtD
Finasteride—CYP3A4—Rufinamide—epilepsy syndrome	0.0114	0.0161	CbGbCtD
Finasteride—CYP3A4—Carbamazepine—epilepsy syndrome	0.0111	0.0157	CbGbCtD
Finasteride—CYP3A4—Primidone—epilepsy syndrome	0.0104	0.0147	CbGbCtD
Finasteride—CYP3A4—Phenytoin—epilepsy syndrome	0.00995	0.0141	CbGbCtD
Finasteride—CYP3A4—Propofol—epilepsy syndrome	0.00928	0.0131	CbGbCtD
Finasteride—CYP3A4—Acetazolamide—epilepsy syndrome	0.00887	0.0126	CbGbCtD
Finasteride—CYP3A4—Phenobarbital—epilepsy syndrome	0.00887	0.0126	CbGbCtD
Finasteride—CYP3A4—Midazolam—epilepsy syndrome	0.00874	0.0124	CbGbCtD
Finasteride—CYP3A4—Diazepam—epilepsy syndrome	0.00841	0.0119	CbGbCtD
Finasteride—CYP3A4—Zonisamide—epilepsy syndrome	0.0082	0.0116	CbGbCtD
Finasteride—CYP3A4—Valproic Acid—epilepsy syndrome	0.00663	0.00939	CbGbCtD
Finasteride—CYP3A4—Topiramate—epilepsy syndrome	0.00598	0.00847	CbGbCtD
Finasteride—Medrysone—NR3C1—epilepsy syndrome	0.000583	0.237	CrCbGaD
Finasteride—Testosterone—SLCO1A2—epilepsy syndrome	0.00045	0.183	CrCbGaD
Finasteride—Testosterone—CYP11A1—epilepsy syndrome	0.000392	0.159	CrCbGaD
Finasteride—Asthenia—Clobazam—epilepsy syndrome	0.000306	0.00147	CcSEcCtD
Finasteride—Infection—Felbamate—epilepsy syndrome	0.000304	0.00146	CcSEcCtD
Finasteride—Somnolence—Levetiracetam—epilepsy syndrome	0.000303	0.00146	CcSEcCtD
Finasteride—Urticaria—Acetazolamide—epilepsy syndrome	0.000302	0.00145	CcSEcCtD
Finasteride—Pain—Propofol—epilepsy syndrome	0.000302	0.00145	CcSEcCtD
Finasteride—Pruritus—Clobazam—epilepsy syndrome	0.000301	0.00145	CcSEcCtD
Finasteride—Rash—Phenobarbital—epilepsy syndrome	0.0003	0.00145	CcSEcCtD
Finasteride—Dermatitis—Phenobarbital—epilepsy syndrome	0.0003	0.00145	CcSEcCtD
Finasteride—Headache—Phenobarbital—epilepsy syndrome	0.000298	0.00144	CcSEcCtD
Finasteride—Infection—Zonisamide—epilepsy syndrome	0.000297	0.00143	CcSEcCtD
Finasteride—Rhinitis—Valproic Acid—epilepsy syndrome	0.000296	0.00143	CcSEcCtD
Finasteride—Angioedema—Lamotrigine—epilepsy syndrome	0.000296	0.00142	CcSEcCtD
Finasteride—Disturbance in sexual arousal—Topiramate—epilepsy syndrome	0.000295	0.00142	CcSEcCtD
Finasteride—Pain—Midazolam—epilepsy syndrome	0.000295	0.00142	CcSEcCtD
Finasteride—Hypotension—Diazepam—epilepsy syndrome	0.000295	0.00142	CcSEcCtD
Finasteride—Rash—Rufinamide—epilepsy syndrome	0.000295	0.00142	CcSEcCtD
Finasteride—Dermatitis—Rufinamide—epilepsy syndrome	0.000295	0.00142	CcSEcCtD
Finasteride—Bronchitis—Gabapentin—epilepsy syndrome	0.000294	0.00142	CcSEcCtD
Finasteride—Dyspnoea—Fosphenytoin—epilepsy syndrome	0.000293	0.00141	CcSEcCtD
Finasteride—Pharyngitis—Valproic Acid—epilepsy syndrome	0.000293	0.00141	CcSEcCtD
Finasteride—Headache—Rufinamide—epilepsy syndrome	0.000293	0.00141	CcSEcCtD
Finasteride—Somnolence—Fosphenytoin—epilepsy syndrome	0.000292	0.00141	CcSEcCtD
Finasteride—Pain—Levetiracetam—epilepsy syndrome	0.000291	0.0014	CcSEcCtD
Finasteride—Oedema peripheral—Valproic Acid—epilepsy syndrome	0.000291	0.0014	CcSEcCtD
Finasteride—Dizziness—Lacosamide—epilepsy syndrome	0.00029	0.0014	CcSEcCtD
Finasteride—Infection—Clonazepam—epilepsy syndrome	0.000286	0.00138	CcSEcCtD
Finasteride—Hypotension—Felbamate—epilepsy syndrome	0.000285	0.00138	CcSEcCtD
Finasteride—Somnolence—Vigabatrin—epilepsy syndrome	0.000285	0.00137	CcSEcCtD
Finasteride—Infection—Phenytoin—epilepsy syndrome	0.000284	0.00137	CcSEcCtD
Finasteride—Infection—Oxcarbazepine—epilepsy syndrome	0.000283	0.00136	CcSEcCtD
Finasteride—Erectile dysfunction—Gabapentin—epilepsy syndrome	0.000282	0.00136	CcSEcCtD
Finasteride—Dizziness—Clobazam—epilepsy syndrome	0.000282	0.00136	CcSEcCtD
Finasteride—Dyspnoea—Diazepam—epilepsy syndrome	0.000281	0.00136	CcSEcCtD
Finasteride—Somnolence—Diazepam—epilepsy syndrome	0.000281	0.00135	CcSEcCtD
Finasteride—Urticaria—Propofol—epilepsy syndrome	0.00028	0.00135	CcSEcCtD
Finasteride—Hypotension—Zonisamide—epilepsy syndrome	0.000279	0.00135	CcSEcCtD
Finasteride—Sinusitis—Pregabalin—epilepsy syndrome	0.000279	0.00134	CcSEcCtD
Finasteride—Rash—Lacosamide—epilepsy syndrome	0.000277	0.00133	CcSEcCtD
Finasteride—Dermatitis—Lacosamide—epilepsy syndrome	0.000277	0.00133	CcSEcCtD
Finasteride—Headache—Lacosamide—epilepsy syndrome	0.000275	0.00133	CcSEcCtD
Finasteride—Pain—Vigabatrin—epilepsy syndrome	0.000274	0.00132	CcSEcCtD
Finasteride—Urticaria—Midazolam—epilepsy syndrome	0.000274	0.00132	CcSEcCtD
Finasteride—Asthenia—Acetazolamide—epilepsy syndrome	0.000272	0.00131	CcSEcCtD
Finasteride—Dyspnoea—Felbamate—epilepsy syndrome	0.000272	0.00131	CcSEcCtD
Finasteride—Orthostatic hypotension—Topiramate—epilepsy syndrome	0.000272	0.00131	CcSEcCtD
Finasteride—Somnolence—Felbamate—epilepsy syndrome	0.000272	0.00131	CcSEcCtD
Finasteride—Infection—Carbamazepine—epilepsy syndrome	0.000271	0.00131	CcSEcCtD
Finasteride—Pain—Diazepam—epilepsy syndrome	0.00027	0.0013	CcSEcCtD
Finasteride—Hypotension—Clonazepam—epilepsy syndrome	0.000269	0.0013	CcSEcCtD
Finasteride—Breast disorder—Topiramate—epilepsy syndrome	0.000269	0.0013	CcSEcCtD
Finasteride—Rash—Clobazam—epilepsy syndrome	0.000269	0.00129	CcSEcCtD
Finasteride—Dermatitis—Clobazam—epilepsy syndrome	0.000268	0.00129	CcSEcCtD
Finasteride—Rhinitis—Pregabalin—epilepsy syndrome	0.000268	0.00129	CcSEcCtD
Finasteride—Hypotension—Phenytoin—epilepsy syndrome	0.000268	0.00129	CcSEcCtD
Finasteride—Headache—Clobazam—epilepsy syndrome	0.000267	0.00129	CcSEcCtD
Finasteride—Immune system disorder—Valproic Acid—epilepsy syndrome	0.000267	0.00129	CcSEcCtD
Finasteride—Dyspnoea—Zonisamide—epilepsy syndrome	0.000267	0.00128	CcSEcCtD
Finasteride—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000266	0.00128	CcSEcCtD
Finasteride—Somnolence—Zonisamide—epilepsy syndrome	0.000266	0.00128	CcSEcCtD
Finasteride—Pharyngitis—Pregabalin—epilepsy syndrome	0.000265	0.00128	CcSEcCtD
Finasteride—Oedema peripheral—Pregabalin—epilepsy syndrome	0.000263	0.00127	CcSEcCtD
Finasteride—Infection—Lamotrigine—epilepsy syndrome	0.000262	0.00126	CcSEcCtD
Finasteride—Urticaria—Fosphenytoin—epilepsy syndrome	0.000261	0.00126	CcSEcCtD
Finasteride—Pain—Felbamate—epilepsy syndrome	0.000261	0.00126	CcSEcCtD
Finasteride—Mental disorder—Valproic Acid—epilepsy syndrome	0.000259	0.00125	CcSEcCtD
Finasteride—Dyspnoea—Clonazepam—epilepsy syndrome	0.000257	0.00124	CcSEcCtD
Finasteride—Somnolence—Clonazepam—epilepsy syndrome	0.000256	0.00123	CcSEcCtD
Finasteride—Sinusitis—Gabapentin—epilepsy syndrome	0.000256	0.00123	CcSEcCtD
Finasteride—Hypotension—Carbamazepine—epilepsy syndrome	0.000255	0.00123	CcSEcCtD
Finasteride—Dyspnoea—Phenytoin—epilepsy syndrome	0.000255	0.00123	CcSEcCtD
Finasteride—Urticaria—Vigabatrin—epilepsy syndrome	0.000255	0.00123	CcSEcCtD
Finasteride—Somnolence—Phenytoin—epilepsy syndrome	0.000255	0.00123	CcSEcCtD
Finasteride—Hypersensitivity—Midazolam—epilepsy syndrome	0.000254	0.00123	CcSEcCtD
Finasteride—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000254	0.00122	CcSEcCtD
Finasteride—Somnolence—Oxcarbazepine—epilepsy syndrome	0.000253	0.00122	CcSEcCtD
Finasteride—Asthenia—Propofol—epilepsy syndrome	0.000253	0.00122	CcSEcCtD
Finasteride—Dizziness—Acetazolamide—epilepsy syndrome	0.000251	0.00121	CcSEcCtD
Finasteride—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000251	0.00121	CcSEcCtD
Finasteride—Urticaria—Diazepam—epilepsy syndrome	0.000251	0.00121	CcSEcCtD
Finasteride—Pruritus—Propofol—epilepsy syndrome	0.00025	0.0012	CcSEcCtD
Finasteride—Asthenia—Midazolam—epilepsy syndrome	0.000248	0.00119	CcSEcCtD
Finasteride—Bronchitis—Topiramate—epilepsy syndrome	0.000248	0.00119	CcSEcCtD
Finasteride—Pain—Clonazepam—epilepsy syndrome	0.000246	0.00119	CcSEcCtD
Finasteride—Rhinitis—Gabapentin—epilepsy syndrome	0.000246	0.00118	CcSEcCtD
Finasteride—Asthenia—Levetiracetam—epilepsy syndrome	0.000245	0.00118	CcSEcCtD
Finasteride—Pruritus—Midazolam—epilepsy syndrome	0.000244	0.00118	CcSEcCtD
Finasteride—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000244	0.00117	CcSEcCtD
Finasteride—Pain—Oxcarbazepine—epilepsy syndrome	0.000244	0.00117	CcSEcCtD
Finasteride—Pharyngitis—Gabapentin—epilepsy syndrome	0.000243	0.00117	CcSEcCtD
Finasteride—Somnolence—Carbamazepine—epilepsy syndrome	0.000243	0.00117	CcSEcCtD
Finasteride—Urticaria—Felbamate—epilepsy syndrome	0.000243	0.00117	CcSEcCtD
Finasteride—Oedema peripheral—Gabapentin—epilepsy syndrome	0.000241	0.00116	CcSEcCtD
Finasteride—Immune system disorder—Pregabalin—epilepsy syndrome	0.000241	0.00116	CcSEcCtD
Finasteride—Pruritus—Levetiracetam—epilepsy syndrome	0.000241	0.00116	CcSEcCtD
Finasteride—Headache—Acetazolamide—epilepsy syndrome	0.000238	0.00115	CcSEcCtD
Finasteride—Urticaria—Zonisamide—epilepsy syndrome	0.000238	0.00114	CcSEcCtD
Finasteride—Erectile dysfunction—Topiramate—epilepsy syndrome	0.000237	0.00114	CcSEcCtD
Finasteride—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000236	0.00114	CcSEcCtD
Finasteride—Asthenia—Fosphenytoin—epilepsy syndrome	0.000236	0.00114	CcSEcCtD
Finasteride—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000235	0.00113	CcSEcCtD
Finasteride—Angioedema—Valproic Acid—epilepsy syndrome	0.000235	0.00113	CcSEcCtD
Finasteride—Somnolence—Lamotrigine—epilepsy syndrome	0.000235	0.00113	CcSEcCtD
Finasteride—Mental disorder—Pregabalin—epilepsy syndrome	0.000234	0.00113	CcSEcCtD
Finasteride—Pain—Carbamazepine—epilepsy syndrome	0.000234	0.00113	CcSEcCtD
Finasteride—Dizziness—Propofol—epilepsy syndrome	0.000233	0.00112	CcSEcCtD
Finasteride—Pruritus—Fosphenytoin—epilepsy syndrome	0.000233	0.00112	CcSEcCtD
Finasteride—Hypersensitivity—Diazepam—epilepsy syndrome	0.000233	0.00112	CcSEcCtD
Finasteride—Asthenia—Vigabatrin—epilepsy syndrome	0.00023	0.00111	CcSEcCtD
Finasteride—Urticaria—Clonazepam—epilepsy syndrome	0.000229	0.0011	CcSEcCtD
Finasteride—Dizziness—Midazolam—epilepsy syndrome	0.000228	0.0011	CcSEcCtD
Finasteride—Urticaria—Phenytoin—epilepsy syndrome	0.000227	0.0011	CcSEcCtD
Finasteride—Pruritus—Vigabatrin—epilepsy syndrome	0.000227	0.00109	CcSEcCtD
Finasteride—Asthenia—Diazepam—epilepsy syndrome	0.000226	0.00109	CcSEcCtD
Finasteride—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000226	0.00109	CcSEcCtD
Finasteride—Pain—Lamotrigine—epilepsy syndrome	0.000226	0.00109	CcSEcCtD
Finasteride—Dizziness—Levetiracetam—epilepsy syndrome	0.000225	0.00109	CcSEcCtD
Finasteride—Pruritus—Diazepam—epilepsy syndrome	0.000223	0.00108	CcSEcCtD
Finasteride—Rash—Propofol—epilepsy syndrome	0.000222	0.00107	CcSEcCtD
Finasteride—Dermatitis—Propofol—epilepsy syndrome	0.000222	0.00107	CcSEcCtD
Finasteride—Immune system disorder—Gabapentin—epilepsy syndrome	0.000221	0.00107	CcSEcCtD
Finasteride—Headache—Propofol—epilepsy syndrome	0.000221	0.00106	CcSEcCtD
Finasteride—Hypersensitivity—Zonisamide—epilepsy syndrome	0.00022	0.00106	CcSEcCtD
Finasteride—Asthenia—Felbamate—epilepsy syndrome	0.000219	0.00106	CcSEcCtD
Finasteride—Rash—Midazolam—epilepsy syndrome	0.000218	0.00105	CcSEcCtD
Finasteride—Dizziness—Fosphenytoin—epilepsy syndrome	0.000218	0.00105	CcSEcCtD
Finasteride—Dermatitis—Midazolam—epilepsy syndrome	0.000217	0.00105	CcSEcCtD
Finasteride—Urticaria—Carbamazepine—epilepsy syndrome	0.000217	0.00105	CcSEcCtD
Finasteride—Headache—Midazolam—epilepsy syndrome	0.000216	0.00104	CcSEcCtD
Finasteride—Pruritus—Felbamate—epilepsy syndrome	0.000216	0.00104	CcSEcCtD
Finasteride—Sinusitis—Topiramate—epilepsy syndrome	0.000215	0.00104	CcSEcCtD
Finasteride—Rash—Levetiracetam—epilepsy syndrome	0.000215	0.00104	CcSEcCtD
Finasteride—Dermatitis—Levetiracetam—epilepsy syndrome	0.000215	0.00103	CcSEcCtD
Finasteride—Asthenia—Zonisamide—epilepsy syndrome	0.000215	0.00103	CcSEcCtD
Finasteride—Mental disorder—Gabapentin—epilepsy syndrome	0.000215	0.00103	CcSEcCtD
Finasteride—Headache—Levetiracetam—epilepsy syndrome	0.000214	0.00103	CcSEcCtD
Finasteride—Angioedema—Pregabalin—epilepsy syndrome	0.000212	0.00102	CcSEcCtD
Finasteride—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000212	0.00102	CcSEcCtD
Finasteride—Dizziness—Vigabatrin—epilepsy syndrome	0.000212	0.00102	CcSEcCtD
Finasteride—Pruritus—Zonisamide—epilepsy syndrome	0.000212	0.00102	CcSEcCtD
Finasteride—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000211	0.00102	CcSEcCtD
Finasteride—Urticaria—Lamotrigine—epilepsy syndrome	0.00021	0.00101	CcSEcCtD
Finasteride—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.00021	0.00101	CcSEcCtD
Finasteride—Dizziness—Diazepam—epilepsy syndrome	0.000209	0.00101	CcSEcCtD
Finasteride—Infection—Valproic Acid—epilepsy syndrome	0.000208	0.001	CcSEcCtD
Finasteride—Rash—Fosphenytoin—epilepsy syndrome	0.000207	0.000999	CcSEcCtD
Finasteride—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000207	0.000998	CcSEcCtD
Finasteride—Asthenia—Clonazepam—epilepsy syndrome	0.000207	0.000996	CcSEcCtD
Finasteride—Rhinitis—Topiramate—epilepsy syndrome	0.000207	0.000995	CcSEcCtD
Finasteride—Headache—Fosphenytoin—epilepsy syndrome	0.000206	0.000993	CcSEcCtD
Finasteride—Asthenia—Phenytoin—epilepsy syndrome	0.000205	0.00099	CcSEcCtD
Finasteride—Pharyngitis—Topiramate—epilepsy syndrome	0.000204	0.000985	CcSEcCtD
Finasteride—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000204	0.000985	CcSEcCtD
Finasteride—Pruritus—Clonazepam—epilepsy syndrome	0.000204	0.000983	CcSEcCtD
Finasteride—Oedema peripheral—Topiramate—epilepsy syndrome	0.000203	0.000978	CcSEcCtD
Finasteride—Pruritus—Phenytoin—epilepsy syndrome	0.000203	0.000976	CcSEcCtD
Finasteride—Rash—Vigabatrin—epilepsy syndrome	0.000202	0.000974	CcSEcCtD
Finasteride—Dizziness—Felbamate—epilepsy syndrome	0.000202	0.000973	CcSEcCtD
Finasteride—Dermatitis—Vigabatrin—epilepsy syndrome	0.000202	0.000973	CcSEcCtD
Finasteride—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000201	0.000971	CcSEcCtD
Finasteride—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000201	0.00097	CcSEcCtD
Finasteride—Headache—Vigabatrin—epilepsy syndrome	0.000201	0.000968	CcSEcCtD
Finasteride—Rash—Diazepam—epilepsy syndrome	0.000199	0.000959	CcSEcCtD
Finasteride—Dermatitis—Diazepam—epilepsy syndrome	0.000199	0.000958	CcSEcCtD
Finasteride—Dizziness—Zonisamide—epilepsy syndrome	0.000198	0.000953	CcSEcCtD
Finasteride—Headache—Diazepam—epilepsy syndrome	0.000198	0.000953	CcSEcCtD
Finasteride—Hypotension—Valproic Acid—epilepsy syndrome	0.000196	0.000945	CcSEcCtD
Finasteride—Asthenia—Carbamazepine—epilepsy syndrome	0.000196	0.000945	CcSEcCtD
Finasteride—Angioedema—Gabapentin—epilepsy syndrome	0.000195	0.000939	CcSEcCtD
Finasteride—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000195	0.000938	CcSEcCtD
Finasteride—Pruritus—Carbamazepine—epilepsy syndrome	0.000193	0.000932	CcSEcCtD
Finasteride—Rash—Felbamate—epilepsy syndrome	0.000193	0.000928	CcSEcCtD
Finasteride—Dermatitis—Felbamate—epilepsy syndrome	0.000192	0.000927	CcSEcCtD
Finasteride—Headache—Felbamate—epilepsy syndrome	0.000191	0.000922	CcSEcCtD
Finasteride—Dizziness—Clonazepam—epilepsy syndrome	0.000191	0.000918	CcSEcCtD
Finasteride—Testosterone—ABCG2—epilepsy syndrome	0.00019	0.0774	CrCbGaD
Finasteride—Asthenia—Lamotrigine—epilepsy syndrome	0.000189	0.000913	CcSEcCtD
Finasteride—Dizziness—Phenytoin—epilepsy syndrome	0.000189	0.000912	CcSEcCtD
Finasteride—Rash—Zonisamide—epilepsy syndrome	0.000189	0.000909	CcSEcCtD
Finasteride—Infection—Pregabalin—epilepsy syndrome	0.000188	0.000908	CcSEcCtD
Finasteride—Dermatitis—Zonisamide—epilepsy syndrome	0.000188	0.000908	CcSEcCtD
Finasteride—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000188	0.000907	CcSEcCtD
Finasteride—Headache—Zonisamide—epilepsy syndrome	0.000187	0.000903	CcSEcCtD
Finasteride—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000187	0.000902	CcSEcCtD
Finasteride—Pruritus—Lamotrigine—epilepsy syndrome	0.000187	0.0009	CcSEcCtD
Finasteride—Somnolence—Valproic Acid—epilepsy syndrome	0.000187	0.000899	CcSEcCtD
Finasteride—Immune system disorder—Topiramate—epilepsy syndrome	0.000186	0.000897	CcSEcCtD
Finasteride—Rash—Clonazepam—epilepsy syndrome	0.000182	0.000876	CcSEcCtD
Finasteride—Dermatitis—Clonazepam—epilepsy syndrome	0.000182	0.000875	CcSEcCtD
Finasteride—Dizziness—Carbamazepine—epilepsy syndrome	0.000181	0.000871	CcSEcCtD
Finasteride—Headache—Clonazepam—epilepsy syndrome	0.000181	0.00087	CcSEcCtD
Finasteride—Rash—Phenytoin—epilepsy syndrome	0.000181	0.00087	CcSEcCtD
Finasteride—Mental disorder—Topiramate—epilepsy syndrome	0.00018	0.00087	CcSEcCtD
Finasteride—Dermatitis—Phenytoin—epilepsy syndrome	0.00018	0.000869	CcSEcCtD
Finasteride—Rash—Oxcarbazepine—epilepsy syndrome	0.00018	0.000865	CcSEcCtD
Finasteride—Pain—Valproic Acid—epilepsy syndrome	0.000179	0.000865	CcSEcCtD
Finasteride—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000179	0.000864	CcSEcCtD
Finasteride—Headache—Phenytoin—epilepsy syndrome	0.000179	0.000864	CcSEcCtD
Finasteride—Headache—Oxcarbazepine—epilepsy syndrome	0.000178	0.00086	CcSEcCtD
Finasteride—Hypotension—Pregabalin—epilepsy syndrome	0.000177	0.000854	CcSEcCtD
Finasteride—Dizziness—Lamotrigine—epilepsy syndrome	0.000175	0.000842	CcSEcCtD
Finasteride—Progesterone—NR3C1—epilepsy syndrome	0.000174	0.0706	CrCbGaD
Finasteride—Infection—Gabapentin—epilepsy syndrome	0.000173	0.000833	CcSEcCtD
Finasteride—Rash—Carbamazepine—epilepsy syndrome	0.000172	0.00083	CcSEcCtD
Finasteride—Dermatitis—Carbamazepine—epilepsy syndrome	0.000172	0.000829	CcSEcCtD
Finasteride—Headache—Carbamazepine—epilepsy syndrome	0.000171	0.000825	CcSEcCtD
Finasteride—Dyspnoea—Pregabalin—epilepsy syndrome	0.000169	0.000815	CcSEcCtD
Finasteride—Somnolence—Pregabalin—epilepsy syndrome	0.000169	0.000813	CcSEcCtD
Finasteride—Urticaria—Valproic Acid—epilepsy syndrome	0.000167	0.000803	CcSEcCtD
Finasteride—Rash—Lamotrigine—epilepsy syndrome	0.000167	0.000802	CcSEcCtD
Finasteride—Dermatitis—Lamotrigine—epilepsy syndrome	0.000166	0.000802	CcSEcCtD
Finasteride—Headache—Lamotrigine—epilepsy syndrome	0.000165	0.000797	CcSEcCtD
Finasteride—Hypotension—Gabapentin—epilepsy syndrome	0.000163	0.000783	CcSEcCtD
Finasteride—Pain—Pregabalin—epilepsy syndrome	0.000162	0.000782	CcSEcCtD
Finasteride—Progesterone—CYP2C19—epilepsy syndrome	0.000158	0.0643	CrCbGaD
Finasteride—Dyspnoea—Gabapentin—epilepsy syndrome	0.000155	0.000747	CcSEcCtD
Finasteride—Somnolence—Gabapentin—epilepsy syndrome	0.000155	0.000745	CcSEcCtD
Finasteride—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000155	0.000745	CcSEcCtD
Finasteride—Urticaria—Pregabalin—epilepsy syndrome	0.000151	0.000726	CcSEcCtD
Finasteride—Asthenia—Valproic Acid—epilepsy syndrome	0.000151	0.000726	CcSEcCtD
Finasteride—Testosterone—CYP2C19—epilepsy syndrome	0.00015	0.0608	CrCbGaD
Finasteride—Pain—Gabapentin—epilepsy syndrome	0.000149	0.000717	CcSEcCtD
Finasteride—Pruritus—Valproic Acid—epilepsy syndrome	0.000148	0.000715	CcSEcCtD
Finasteride—Infection—Topiramate—epilepsy syndrome	0.000145	0.000701	CcSEcCtD
Finasteride—Hypersensitivity—Pregabalin—epilepsy syndrome	0.00014	0.000674	CcSEcCtD
Finasteride—Dizziness—Valproic Acid—epilepsy syndrome	0.000139	0.000669	CcSEcCtD
Finasteride—Urticaria—Gabapentin—epilepsy syndrome	0.000138	0.000666	CcSEcCtD
Finasteride—Hypotension—Topiramate—epilepsy syndrome	0.000137	0.000659	CcSEcCtD
Finasteride—Asthenia—Pregabalin—epilepsy syndrome	0.000136	0.000656	CcSEcCtD
Finasteride—Pruritus—Pregabalin—epilepsy syndrome	0.000134	0.000647	CcSEcCtD
Finasteride—Rash—Valproic Acid—epilepsy syndrome	0.000132	0.000638	CcSEcCtD
Finasteride—Dermatitis—Valproic Acid—epilepsy syndrome	0.000132	0.000637	CcSEcCtD
Finasteride—Headache—Valproic Acid—epilepsy syndrome	0.000131	0.000634	CcSEcCtD
Finasteride—Dyspnoea—Topiramate—epilepsy syndrome	0.00013	0.000629	CcSEcCtD
Finasteride—Somnolence—Topiramate—epilepsy syndrome	0.00013	0.000627	CcSEcCtD
Finasteride—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000128	0.000618	CcSEcCtD
Finasteride—Dizziness—Pregabalin—epilepsy syndrome	0.000125	0.000605	CcSEcCtD
Finasteride—Pain—Topiramate—epilepsy syndrome	0.000125	0.000603	CcSEcCtD
Finasteride—Asthenia—Gabapentin—epilepsy syndrome	0.000125	0.000601	CcSEcCtD
Finasteride—Pruritus—Gabapentin—epilepsy syndrome	0.000123	0.000593	CcSEcCtD
Finasteride—Rash—Pregabalin—epilepsy syndrome	0.00012	0.000576	CcSEcCtD
Finasteride—Dermatitis—Pregabalin—epilepsy syndrome	0.00012	0.000576	CcSEcCtD
Finasteride—Headache—Pregabalin—epilepsy syndrome	0.000119	0.000573	CcSEcCtD
Finasteride—Progesterone—CYP2D6—epilepsy syndrome	0.000117	0.0477	CrCbGaD
Finasteride—Urticaria—Topiramate—epilepsy syndrome	0.000116	0.00056	CcSEcCtD
Finasteride—Dizziness—Gabapentin—epilepsy syndrome	0.000115	0.000554	CcSEcCtD
Finasteride—Rash—Gabapentin—epilepsy syndrome	0.00011	0.000529	CcSEcCtD
Finasteride—Dermatitis—Gabapentin—epilepsy syndrome	0.00011	0.000528	CcSEcCtD
Finasteride—Headache—Gabapentin—epilepsy syndrome	0.000109	0.000525	CcSEcCtD
Finasteride—Hypersensitivity—Topiramate—epilepsy syndrome	0.000108	0.00052	CcSEcCtD
Finasteride—Asthenia—Topiramate—epilepsy syndrome	0.000105	0.000506	CcSEcCtD
Finasteride—Pruritus—Topiramate—epilepsy syndrome	0.000104	0.000499	CcSEcCtD
Finasteride—Dizziness—Topiramate—epilepsy syndrome	9.68e-05	0.000466	CcSEcCtD
Finasteride—Rash—Topiramate—epilepsy syndrome	9.23e-05	0.000445	CcSEcCtD
Finasteride—Dermatitis—Topiramate—epilepsy syndrome	9.22e-05	0.000444	CcSEcCtD
Finasteride—Headache—Topiramate—epilepsy syndrome	9.17e-05	0.000442	CcSEcCtD
Finasteride—Progesterone—ABCB1—epilepsy syndrome	8.38e-05	0.0341	CrCbGaD
Finasteride—Testosterone—ALB—epilepsy syndrome	8.31e-05	0.0337	CrCbGaD
Finasteride—Testosterone—ABCB1—epilepsy syndrome	7.93e-05	0.0322	CrCbGaD
Finasteride—SRD5A2—Metabolism—ADRA2A—epilepsy syndrome	7.47e-05	0.000889	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—BCHE—epilepsy syndrome	7.44e-05	0.000885	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—BCHE—epilepsy syndrome	7.44e-05	0.000885	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	7.43e-05	0.000884	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	7.39e-05	0.000879	CbGpPWpGaD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	7.12e-05	0.000847	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—SLC2A1—epilepsy syndrome	7.1e-05	0.000844	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—SLC2A1—epilepsy syndrome	7.1e-05	0.000844	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PLCB1—epilepsy syndrome	7.02e-05	0.000835	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PLCB1—epilepsy syndrome	7.02e-05	0.000835	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.02e-05	0.000835	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—TH—epilepsy syndrome	7e-05	0.000832	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—TH—epilepsy syndrome	7e-05	0.000832	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP2D6—epilepsy syndrome	7e-05	0.000832	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP2C19—epilepsy syndrome	6.98e-05	0.00083	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP11A1—epilepsy syndrome	6.93e-05	0.000825	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.89e-05	0.000819	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.89e-05	0.000819	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP2C19—epilepsy syndrome	6.88e-05	0.000818	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP11A1—epilepsy syndrome	6.84e-05	0.000813	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	6.75e-05	0.000803	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	6.67e-05	0.000793	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ADRA2A—epilepsy syndrome	6.66e-05	0.000792	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—BCHE—epilepsy syndrome	6.63e-05	0.000789	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CA13—epilepsy syndrome	6.6e-05	0.000785	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—SLC2A1—epilepsy syndrome	6.33e-05	0.000753	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PLCB1—epilepsy syndrome	6.26e-05	0.000744	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP2D6—epilepsy syndrome	6.26e-05	0.000744	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—TH—epilepsy syndrome	6.24e-05	0.000742	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP2D6—epilepsy syndrome	6.17e-05	0.000734	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.14e-05	0.00073	CbGpPWpGaD
Finasteride—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	6.13e-05	0.000729	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	6.1e-05	0.000726	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	6.07e-05	0.000722	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—HMOX1—epilepsy syndrome	5.84e-05	0.000694	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—HMOX1—epilepsy syndrome	5.84e-05	0.000694	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	5.77e-05	0.000686	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CAT—epilepsy syndrome	5.76e-05	0.000685	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CAT—epilepsy syndrome	5.76e-05	0.000685	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ABCB1—epilepsy syndrome	5.6e-05	0.000667	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ABCB1—epilepsy syndrome	5.6e-05	0.000667	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	5.48e-05	0.000651	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GPX1—epilepsy syndrome	5.21e-05	0.00062	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GPX1—epilepsy syndrome	5.21e-05	0.00062	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—HMOX1—epilepsy syndrome	5.2e-05	0.000619	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CAT—epilepsy syndrome	5.13e-05	0.000611	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PDXK—epilepsy syndrome	5e-05	0.000595	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CERS1—epilepsy syndrome	5e-05	0.000595	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—L2HGDH—epilepsy syndrome	5e-05	0.000595	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—FAR1—epilepsy syndrome	5e-05	0.000595	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GLUD1—epilepsy syndrome	5e-05	0.000595	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ADK—epilepsy syndrome	5e-05	0.000595	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ABCB1—epilepsy syndrome	4.99e-05	0.000594	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CA13—epilepsy syndrome	4.77e-05	0.000568	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GPX1—epilepsy syndrome	4.64e-05	0.000552	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—EPM2A—epilepsy syndrome	4.58e-05	0.000544	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GAMT—epilepsy syndrome	4.58e-05	0.000544	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NHLRC1—epilepsy syndrome	4.58e-05	0.000544	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PNPO—epilepsy syndrome	4.58e-05	0.000544	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—AGT—epilepsy syndrome	4.57e-05	0.000543	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—AGT—epilepsy syndrome	4.57e-05	0.000543	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—APOE—epilepsy syndrome	4.48e-05	0.000532	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—APOE—epilepsy syndrome	4.48e-05	0.000532	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CA4—epilepsy syndrome	4.25e-05	0.000506	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—QDPR—epilepsy syndrome	4.25e-05	0.000506	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—POMC—epilepsy syndrome	4.24e-05	0.000504	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—AGT—epilepsy syndrome	4.07e-05	0.000484	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—COX3—epilepsy syndrome	4e-05	0.000476	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—APOE—epilepsy syndrome	3.99e-05	0.000475	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—POMC—epilepsy syndrome	3.85e-05	0.000457	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—POMC—epilepsy syndrome	3.85e-05	0.000457	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—KCNB1—epilepsy syndrome	3.79e-05	0.000451	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PFKL—epilepsy syndrome	3.79e-05	0.000451	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC6A8—epilepsy syndrome	3.79e-05	0.000451	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLCO1A2—epilepsy syndrome	3.79e-05	0.000451	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CACNA2D2—epilepsy syndrome	3.79e-05	0.000451	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ADK—epilepsy syndrome	3.62e-05	0.00043	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CERS1—epilepsy syndrome	3.62e-05	0.00043	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PDXK—epilepsy syndrome	3.62e-05	0.00043	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—FAR1—epilepsy syndrome	3.62e-05	0.00043	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GLUD1—epilepsy syndrome	3.62e-05	0.00043	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—L2HGDH—epilepsy syndrome	3.62e-05	0.00043	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ALB—epilepsy syndrome	3.51e-05	0.000417	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ALB—epilepsy syndrome	3.51e-05	0.000417	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NEU1—epilepsy syndrome	3.47e-05	0.000412	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ATIC—epilepsy syndrome	3.47e-05	0.000412	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—UPB1—epilepsy syndrome	3.47e-05	0.000412	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—POMC—epilepsy syndrome	3.43e-05	0.000408	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HSD17B4—epilepsy syndrome	3.34e-05	0.000397	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	3.31e-05	0.000394	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NHLRC1—epilepsy syndrome	3.31e-05	0.000393	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PNPO—epilepsy syndrome	3.31e-05	0.000393	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GAMT—epilepsy syndrome	3.31e-05	0.000393	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—EPM2A—epilepsy syndrome	3.31e-05	0.000393	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	3.24e-05	0.000386	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GBE1—epilepsy syndrome	3.22e-05	0.000383	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PPP1R3C—epilepsy syndrome	3.22e-05	0.000383	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	3.22e-05	0.000383	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	3.2e-05	0.00038	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	3.18e-05	0.000378	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ALB—epilepsy syndrome	3.12e-05	0.000372	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—QDPR—epilepsy syndrome	3.07e-05	0.000366	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CA4—epilepsy syndrome	3.07e-05	0.000366	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PTGS2—epilepsy syndrome	3.07e-05	0.000365	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PTGS2—epilepsy syndrome	3.07e-05	0.000365	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—POMC—epilepsy syndrome	3.07e-05	0.000365	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ASAH1—epilepsy syndrome	3.03e-05	0.000361	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—STXBP1—epilepsy syndrome	2.95e-05	0.000351	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	2.91e-05	0.000346	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—COX3—epilepsy syndrome	2.89e-05	0.000344	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NT5E—epilepsy syndrome	2.87e-05	0.000342	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ALAD—epilepsy syndrome	2.87e-05	0.000342	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.87e-05	0.000341	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ALDH7A1—epilepsy syndrome	2.74e-05	0.000326	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CACNA1A—epilepsy syndrome	2.74e-05	0.000326	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC6A8—epilepsy syndrome	2.74e-05	0.000326	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PFKL—epilepsy syndrome	2.74e-05	0.000326	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLCO1A2—epilepsy syndrome	2.74e-05	0.000326	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CACNA2D2—epilepsy syndrome	2.74e-05	0.000326	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—KCNB1—epilepsy syndrome	2.74e-05	0.000326	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PTGS2—epilepsy syndrome	2.73e-05	0.000325	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.68e-05	0.000319	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ST3GAL3—epilepsy syndrome	2.68e-05	0.000319	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ADSL—epilepsy syndrome	2.63e-05	0.000313	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GLUL—epilepsy syndrome	2.58e-05	0.000307	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CACNA1D—epilepsy syndrome	2.53e-05	0.000301	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ATIC—epilepsy syndrome	2.51e-05	0.000298	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NEU1—epilepsy syndrome	2.51e-05	0.000298	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—UPB1—epilepsy syndrome	2.51e-05	0.000298	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HSD17B4—epilepsy syndrome	2.41e-05	0.000287	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—TXNRD1—epilepsy syndrome	2.37e-05	0.000281	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PPP1R3C—epilepsy syndrome	2.33e-05	0.000277	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GBE1—epilepsy syndrome	2.33e-05	0.000277	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—AQP1—epilepsy syndrome	2.3e-05	0.000273	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.22e-05	0.000264	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ASAH1—epilepsy syndrome	2.19e-05	0.000261	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—STXBP1—epilepsy syndrome	2.13e-05	0.000254	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—KCNJ11—epilepsy syndrome	2.08e-05	0.000247	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CHRM3—epilepsy syndrome	2.08e-05	0.000247	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NT5E—epilepsy syndrome	2.08e-05	0.000247	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ALAD—epilepsy syndrome	2.08e-05	0.000247	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ALDH7A1—epilepsy syndrome	1.98e-05	0.000236	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CACNA1A—epilepsy syndrome	1.98e-05	0.000236	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ST3GAL3—epilepsy syndrome	1.94e-05	0.000231	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ADSL—epilepsy syndrome	1.9e-05	0.000226	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GLUL—epilepsy syndrome	1.86e-05	0.000222	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CACNA1D—epilepsy syndrome	1.83e-05	0.000217	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—TXNRD1—epilepsy syndrome	1.71e-05	0.000203	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ABCG2—epilepsy syndrome	1.69e-05	0.000201	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.68e-05	0.0002	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.68e-05	0.0002	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.68e-05	0.0002	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.68e-05	0.0002	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.68e-05	0.0002	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.68e-05	0.0002	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—AQP1—epilepsy syndrome	1.66e-05	0.000197	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP2C19—epilepsy syndrome	1.65e-05	0.000196	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP11A1—epilepsy syndrome	1.64e-05	0.000195	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—AKT1—epilepsy syndrome	1.54e-05	0.000183	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—AKT1—epilepsy syndrome	1.54e-05	0.000183	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.54e-05	0.000183	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.54e-05	0.000183	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.54e-05	0.000183	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.54e-05	0.000183	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	1.5e-05	0.000179	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	1.5e-05	0.000179	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	1.48e-05	0.000176	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.43e-05	0.00017	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.43e-05	0.00017	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.42e-05	0.000169	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	1.41e-05	0.000168	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—BCHE—epilepsy syndrome	1.4e-05	0.000167	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—AKT1—epilepsy syndrome	1.37e-05	0.000163	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.34e-05	0.00016	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	1.34e-05	0.000159	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	1.32e-05	0.000157	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—TH—epilepsy syndrome	1.32e-05	0.000157	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.27e-05	0.000152	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.27e-05	0.000152	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.27e-05	0.000152	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.27e-05	0.000152	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.27e-05	0.000152	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	1.22e-05	0.000146	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	1.19e-05	0.000142	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	1.19e-05	0.000141	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.17e-05	0.000139	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.17e-05	0.000139	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.17e-05	0.000139	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.12e-05	0.000133	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	1.1e-05	0.000131	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CAT—epilepsy syndrome	1.09e-05	0.000129	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.08e-05	0.000129	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.08e-05	0.000129	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	1.07e-05	0.000127	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	1.06e-05	0.000126	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.02e-05	0.000121	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	1.02e-05	0.000121	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—BCHE—epilepsy syndrome	1.01e-05	0.000121	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	9.91e-06	0.000118	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GPX1—epilepsy syndrome	9.82e-06	0.000117	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	9.68e-06	0.000115	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ALAD—epilepsy syndrome	9.66e-06	0.000115	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NT5E—epilepsy syndrome	9.66e-06	0.000115	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	9.57e-06	0.000114	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—TH—epilepsy syndrome	9.54e-06	0.000113	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	9.21e-06	0.00011	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	9.21e-06	0.00011	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	9.01e-06	0.000107	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ADSL—epilepsy syndrome	8.83e-06	0.000105	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GLUL—epilepsy syndrome	8.66e-06	0.000103	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—AGT—epilepsy syndrome	8.62e-06	0.000102	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	8.5e-06	0.000101	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—APOE—epilepsy syndrome	8.44e-06	0.0001	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	7.96e-06	9.47e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	7.95e-06	9.46e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CAT—epilepsy syndrome	7.85e-06	9.34e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—AQP1—epilepsy syndrome	7.72e-06	9.18e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	7.64e-06	9.09e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—POMC—epilepsy syndrome	7.25e-06	8.63e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GPX1—epilepsy syndrome	7.1e-06	8.45e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	6.98e-06	8.3e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	6.98e-06	8.3e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ALB—epilepsy syndrome	6.61e-06	7.86e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—AGT—epilepsy syndrome	6.23e-06	7.41e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—APOE—epilepsy syndrome	6.1e-06	7.26e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	5.78e-06	6.88e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	5.69e-06	6.77e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	5.55e-06	6.6e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	5.51e-06	6.56e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—POMC—epilepsy syndrome	5.24e-06	6.23e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.97e-06	5.92e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ALB—epilepsy syndrome	4.78e-06	5.68e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	4.74e-06	5.63e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—BCHE—epilepsy syndrome	4.72e-06	5.61e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	4.5e-06	5.35e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	4.45e-06	5.29e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—TH—epilepsy syndrome	4.43e-06	5.27e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	4.18e-06	4.97e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.7e-06	4.4e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.65e-06	4.34e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	3.55e-06	4.22e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.3e-06	3.93e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—AKT1—epilepsy syndrome	2.91e-06	3.46e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.9e-06	3.44e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.84e-06	3.37e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.44e-06	2.9e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.22e-06	2.64e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—AKT1—epilepsy syndrome	2.1e-06	2.5e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.94e-06	2.31e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—AKT1—epilepsy syndrome	9.77e-07	1.16e-05	CbGpPWpGaD
